ABIVAX SA (AAVXF:OTCMKTS)
$126 10.35 (8.9494%)
Analysed ABIVAX SA (AAVXF:OTCMKTS) News Sources
Dianthus Therapeutics Is Up 320% in a Year. One Major Investor Just Reduced Its Stake but Still Seems Bullish
18-05-2026
fool.com
What to Know About This Fund’s New $22 Million Xenon Pharmaceuticals Buy Ahead of an FDA Filing
18-05-2026
fool.com
Hedge Fund Drops $37 Million on Rare Disease Biotech Crinetics. Is It a Buy?
18-05-2026
fool.com
Hedge Fund Drops $40 Million on Gene-Editing Biotech Beam. Is It a Buy?
18-05-2026
fool.com
Hedge Fund Wagers $36 Million on Biotech Denali After First FDA Approval
18-05-2026
fool.com
What This Fund’s $14 Million Ocular Therapeutix Exit Could Signal for Investors
19-05-2026
fool.com
Dyne Therapeutics Is Up 40%, but One Biotech Fund Just Disclosed Selling $14 Million Worth of Shares
19-05-2026
fool.com
2 Stocks That Could Realistically Double by 2030
22-05-2026
fool.com
Abivax Presents First Quarter 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with Ulcerative Colitis
22-05-2026
yahoo.com
ABIVAX Société Anonyme (ENXTPA:ABVX) Is Up 6.9% After Long-Term Obefazimod Data And Q1 Results - Has The Bull Case Changed?
24-05-2026
yahoo.com
What is the current price of ABIVAX SA (AAVXF:OTCMKTS)?
The current price of ABIVAX SA (AAVXF:OTCMKTS) is $126.
ABIVAX SA (AAVXF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of ABIVAX SA (AAVXF:OTCMKTS) since the previous trading day is $10.35.
ABIVAX SA (AAVXF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of ABIVAX SA (AAVXF:OTCMKTS) since the previous trading day is 8.9494%.
What is the most recent average sentiment score for ABIVAX SA (AAVXF:OTCMKTS)?
The most recent average sentiment score for ABIVAX SA (AAVXF:OTCMKTS) is 86 out of 100.
What is the most recent average sentiment for ABIVAX SA (AAVXF:OTCMKTS)?
The most recent sentiment for ABIVAX SA (AAVXF:OTCMKTS) is .
SEC-8K** Filing Available For ABIVAX SA (AAVXF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.